The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
The oral poliovirus vaccine (OPV), which prevents person-to-person transmission of poliovirus by inducing robust intestinal immunity, has been a crucial tool for global polio eradication. However, polio outbreaks, mainly caused by type 2 circulating vaccine-derived poliovirus (cVDPV2), are increasing worldwide. Meanwhile, immunodeficiency-associated vaccine-derived poliovirus (iVDPV) is considered another risk factor during the final stage of global polio eradication. Patients with primary immunodeficiency diseases are associated with higher risks for long-term iVDPV infections. Although a limited number of chronic iVDPV excretors were reported, the recent identification of a chronic type 2 iVDPV (iVDPV2) excretor in the Philippines highlights the potential risk of inapparent iVDPV infection for expanding cVDPV outbreaks. Further research on the genetic characterizations and molecular evolution of iVDPV2, based on comprehensive iVDPV surveillance, will be critical for elucidating the remaining risk of iVDPV2 during the post-OPV era.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The phylogenetic tree of VP1 sequences in 157 iVDPV2 isolates. The sequence alignment was constructed using Clustal Omega, and the tree was inferred using the FastTree 2.1.10 [48] with the GTR model and gamma distribution and visualized with FigTree. Large genetic clusters of each case study are indicated by different colors, red for a chronic excretor in the United Kingdom 1995–2013 [45], blue for the environmental samples from Slovakia in 2003–2005 [43], and green for the stool and oropharyngeal samples from Israel in 2018 [46,47].](https://figures.cochat.ai/paper-figures/1fd64be8bacc4b2d8f77496c6fa5c8c2/the-molecular-evolution-of-type-2-vaccine-derived-polioviruses-in-individuals-figure-1.jpg)
![Figure 2 The frequency of synonymous and non-synonymous substitutions of the VP1 amino acid sequences from 157 iVDPV2 and 567 cVDPV2 isolates. Sequence divergence was analyzed using SNAP (Synonymous Non-synonymous Analysis Program, https://www.hiv.lanl.gov/content/sequence/SNAP/SNAP.html (accessed on 28 May 2021)) [54]. The synonymous (blue crosses) and non-synonymous substitutions (red circles) of the VDPV sequence relative to the Sabin 2 strain are depicted. (A) iVDPV2. (B) cVDPV2.](https://figures.cochat.ai/paper-figures/931302c6bde94e458cb436c111cab22f/the-molecular-evolution-of-type-2-vaccine-derived-polioviruses-in-individuals-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, cVDPV2 is most associated with cVDPV outbreaks. It is a widespread cVDPV and is responsible for most cases of AFP [89].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
Vignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E., & Andino, R. (2006) · Nature · doi:10.1038/nature04388 · Cited by 1,116
SARS-CoV-2 evolution during treatment of chronic infection
Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature · doi:10.1038/s41586-021-03291-y · Cited by 1,097
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600
Self-citationMutational and fitness landscapes of an RNA virus revealed through population sequencing
Acevedo, A., Brodsky, L., & Andino, R. (2014) · Nature · doi:10.1038/nature12861 · Cited by 391
Burns, C. C., Diop, O. M., Sutter, R. W., & Kew, O. M. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu295 · Cited by 309
Engineering attenuated virus vaccines by controlling replication fidelity
Vignuzzi, M., Wendt, E., & Andino, R. (2008) · Nature Medicine · doi:10.1038/nm1726 · Cited by 282
Circulating vaccine-derived polioviruses: current state of knowledge.
Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · PubMed · doi:10.1590/s0042-96862004000100006 · Cited by 258
Self-citationEngineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221
Update on Vaccine-Derived Polioviruses-Worldwide, January 2017–June 2018
Jorba, J., Diop, O. M., Iber, J., Henderson, E., Zhao, K., Sutter, R. W., Wassilak, S. G. F., & Burns, C. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6742a5 · Cited by 197 · cited 1×
“In fact, only two iVDPV2 cases were identified during 2017–2019 [12,31], including a chronic iVDPV2 excretor in the Philippines (see Section 6).”
BackgroundCalibration of multiple poliovirus molecular clocks covering an extended evolutionary range
Jorba, J., Campagnoli, R., De, L., & Kew, O. (2008) · Journal of Virology · doi:10.1128/jvi.02354-07 · Cited by 177
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Self-citationCirculation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Self-citationVan Damme, P., De Coster, I., Bandyopadhyay, A. S., Revets, H., Withanage, K., De Smedt, P., Suykens, L., Oberste, M. S., Weldon, W. C., Costa-Clemens, S. A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31279-6 · Cited by 141
Macklin, G. R., O’Reilly, K. M., Grassly, N. C., Edmunds, W. J., Mach, O., Santhana Gopala Krishnan, R., Voorman, A., Vertefeuille, J. F., Abdelwahab, J., Gumede, N., et al. (2020) · Science · doi:10.1126/science.aba1238 · Cited by 141
Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138
Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees
Cuervo, N. S., Guillot, S., Romanenkova, N., Combiescu, M., Aubert-Combiescu, A., Seghier, M., Caro, V., Crainic, R., & Delpeyroux, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5740-5751.2001 · Cited by 136 · cited 1×
“The recombinant viruses derived from the Sabin 2 capsid sequences with the non-capsid sequences from Sabin 3 or Sabin 1 are frequently detected in healthy vaccinees and VAPP cases in the early stages of virus replication after tOPV immunization [55,62,63].”
BackgroundThe Evolutionary Pathway to Virulence of an RNA Virus
Stern, A., Yeh, M. T., Zinger, T., Smith, M., Wright, C., Ling, G., Nielsen, R., Macadam, A., & Andino, R. (2017) · Cell · doi:10.1016/j.cell.2017.03.013 · Cited by 127
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease
Kingebeni, P. M., Pratt, C. B., Mutafali-Ruffin, M., Pauthner, M. G., Bile, F. N., Nkuba-Ndaye, A., Black, A., Kinganda-Lusamaki, E., Faye, M., Aziza, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2024670 · Cited by 117
Jegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
Parallel evolution of influenza across multiple spatiotemporal scales
Xue, K. S., Stevens-Ayers, T., Campbell, A. P., Englund, J. A., Pergam, S. A., Boeckh, M., & Bloom, J. D. (2017) · eLife · doi:10.7554/elife.26875 · Cited by 114
Shulman, L. M., Manor, Y., Handsher, R., Delpeyroux, F., McDonough, M. J., Halmut, T., Silberstein, I., Alfandari, J., Quay, J., Fisher, T., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3729-3734.2000 · Cited by 109
Dunn, G., Klapsa, D., Wilton, T., Stone, L., Minor, P. D., & Martin, J. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005114 · Cited by 106
Yang, C.-F., Chen, H.-Y., Jorba, J., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y.-C., Lin, T.-Y., Chen, P.-J., Shimizu, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12623-12634.2005 · Cited by 106
Self-citationComputational and Evolutionary Analysis of HIV Molecular Sequences
Rodrigo, A. G., & Learn, G. H. (2001) · Springer eBooks · doi:10.1007/b112102 · Cited by 98
Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar
Rakoto-Andrianarivelo, M., Guillot, S., Iber, J., Balanant, J., Blondel, B., Riquet, F., Martin, J., Kew, O., Randriamanalina, B., Razafinimpiasa, L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030191 · Cited by 96
Arita, M., Zhu, S.-L., Yoshida, H., Yoneyama, T., Miyamura, T., & Shimizu, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12650-12657.2005 · Cited by 95
Self-citationUpdate on Vaccine-Derived Poliovirus Outbreaks — Worldwide, July 2019–February 2020
Alleman, M. M., Jorba, J., Greene, S. A., Diop, O. M., Iber, J., Tallis, G., Goel, A., Wiesen, E., Wassilak, S. G. F., & Burns, C. C. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6916a1 · Cited by 93
Identification and Control of a Poliomyelitis Outbreak in Xinjiang, China
Luo, H., Zhang, Y., Wang, X., Yu, W., Wen, N., Yan, D., Wang, H., Wushouer, F., Wang, H., Xu, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303368 · Cited by 91
Vaccine-Derived Poliomyelitis 12 Years after Infection in Minnesota
DeVries, A. S., Harper, J., Murray, A., Lexau, C., Bahta, L., Christensen, J., Cebelinski, E., Fuller, S., Kline, S., Wallace, G. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008677 · Cited by 88
Perelygina, L., Chen, M.-H., Suppiah, S., Adebayo, A., Abernathy, E., Dorsey, M., Bercovitch, L., Paris, K., White, K. P., Krol, A., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1008080 · Cited by 87
Muslin, C., Joffret, M., Pelletier, I., Blondel, B., & Delpeyroux, F. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005266 · Cited by 86
De Coster, I., Leroux-Roels, I., Bandyopadhyay, A. S., Gast, C., Withanage, K., Steenackers, K., De Smedt, P., Aerssens, A., Leroux-Roels, G., Oberste, M. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32541-1 · Cited by 86
Polio endgame: the global switch from tOPV to bOPV
Garon, J. R., Seib, K. G., Orenstein, W. A., Gonzalez, A. R., Blanc, D. C., Zaffran, M., & Patel, M. M. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1140041 · Cited by 85
Sáez-Llorens, X., Bandyopadhyay, A. S., Gast, C., Leon, T. D., DeAntonio, R., Jimeno, J., Caballero, M. I., Aguirre, G., Oberste, M. S., Weldon, W. C., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32540-x · Cited by 81
Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis
Buttinelli, G., Donati, V., Fiore, S., Marturano, J., Plebani, A., Balestri, P., Soresina, A. R., Vivarelli, R., Delpeyroux, F., Martin, J., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.18974-0 · Cited by 73
Famulare, M., Chang, S., Iber, J., Zhao, K., Adeniji, J. A., Bukbuk, D., Baba, M., Behrend, M., Burns, C. C., & Oberste, M. S. (2016) · Journal of Virology · doi:10.1128/jvi.01532-15 · Cited by 73
Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child
Adu, F., Iber, J. C., Bukbuk, D. N., Gumede, N., Yang, S.-J., Jorba, J. C., Campagnoli, R. P., Sule, W. F., Yang, C.-F., Burns, C. C., et al. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.009 · Cited by 70
Polio eradication at the crossroads
Chumakov, K., Ehrenfeld, E., Agol, V. I., & Wimmer, E. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00205-9 · Cited by 60
(2015) · PubMed Central · Cited by 59
Aghamohammadi, A., Abolhassani, H., Kutukculer, N., Wassilak, S. G., Pallansch, M. A., Kluglein, S., Quinn, J., Sutter, R. W., Wang, X., Sanal, O., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00685 · Cited by 54
Shaghaghi, M., Soleymanjahi, S., Abolhassani, H., Yazdani, R., Azizi, G., Rezaei, N., Barbouche, M., McKinlay, M. A., & Aghamohammadi, A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.059 · Cited by 53
Macklin, G., Diop, O. M., Humayun, A., Shahmahmoodi, S., El-Sayed, Z. A., Triki, H., Rey, G., Avagyan, T., Grabovac, V., Jorba, J., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6928a4 · Cited by 46
Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D., & Martín, J. (2008) · Journal of Virology · doi:10.1128/jvi.00468-08 · Cited by 43
Update on Vaccine-Derived Polioviruses
(2006) · PsycEXTRA Dataset · doi:10.1037/e558982006-002 · Cited by 41
Impact of COVID-19 pandemic on global poliovirus surveillance.
Zomahoun, D. J., Burman, A. L., Snider, C. J., Chauvin, C., Gardner, T., Lickness, J. S., Ahmed, J. A., Diop, O., Gerber, S., & Anand, A. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm695152a4 · Cited by 39 · cited 1×
“The coronavirus disease 2019 (COVID-19) pandemic disrupted the surveillance and immunization activities for vaccine-preventable diseases, including polio, since 2020 [11,29].”
BackgroundKalkowska, D. A., Pallansch, M. A., Cochi, S. L., Kovacs, S., Wassilak, S. G. F., & Thompson, K. M. (2020) · Risk Analysis · doi:10.1111/risa.13555 · Cited by 37
The role of genetic sequencing and analysis in the polio eradication programme
Jorgensen, D., Pons-Salort, M., Shaw, A. G., & Grassly, N. C. (2020) · Virus Evolution · doi:10.1093/ve/veaa040 · Cited by 31 · cited 1×
“The sequence information on cVDPV isolates is expanding due to the current cVDPV outbreaks [34].”
BackgroundValesano, A. L., Taniuchi, M., Fitzsimmons, W. J., Islam, M. O., Ahmed, T., Zaman, K., Haque, R., Wong, W., Famulare, M., & Lauring, A. S. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.10.011 · Cited by 31
Surveillance to Track Progress Toward Polio Eradication-Worldwide, 2019–2020
Tuma, J. N., Wilkinson, A. L., Diop, O. M., Jorba, J., Gardner, T., Snider, C. J., Anand, A., & Ahmed, J. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7018a2 · Cited by 30
Yakovenko, M. L., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Samoilovich, E., Uhova, I., Gavrilin, G. V., & Agol, V. I. (2009) · Journal of Virology · doi:10.1128/jvi.02122-08 · Cited by 29
Tebbens, R. J. D., & Thompson, K. M. (2016) · Epidemiology and Infection · doi:10.1017/s0950268816002302 · Cited by 29
Zhang, Y., Yan, D., Zhu, S., Nishimura, Y., Ye, X., Wang, D., Jorba, J. C., Zhu, H., An, H., Shimizu, H., et al. (2015) · Scientific Reports · doi:10.1038/srep17291 · Cited by 25
Self-citationAdams, A. I., & SALISBURY, D. M. (2015) · Science · doi:10.1126/science.aad7294 · Cited by 25
Adams, A. I., Boualam, L., Diorditsa, S., Gregory, C. J., Jee, Y., Mendoza-Aldana, J., & Roesel, S. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu164 · Cited by 21
Shaw, J., Jorba, J. C., Zhao, K., Iber, J. C., Chen, Q., Adu, F., Adeniji, J. A., Bukbuk, D. N., Baba, M., Henderson, E., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01949-17 · Cited by 21
Zhao, K., Jorba, J. C., Shaw, J., Iber, J. C., Chen, Q., Bullard, K., Kew, O. M., & Burns, C. C. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.09.004 · Cited by 19
Hovi, T., Paananen, A., Blomqvist, S., Savolainen‐Kopra, C., Al‐Hello, H., Smura, T., Shimizu, H., Naďová, K., Sobotová, Z., Gavrilin, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066849 · Cited by 18
Self-citationGurung, S., Harris, J. B., Eltayeb, A. O., Hampton, L. M., Diorditsa, S., Avagyan, T., & Schluter, W. W. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw574 · Cited by 18
Two Cases of Vaccine-Derived Poliovirus Infection in an Oncology Ward
Schubert, A., Böttcher, S., & Eis‐Hübinger, A. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1508104 · Cited by 16
Bauri, M., Wilkinson, A. L., Ropa, B., Feldon, K., Snider, C. J., Anand, A., Tallis, G. F., Boualam, L., Grabovac, V., Avagyan, T., et al. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6805a6 · Cited by 16
Self-citationMcDonald, S. L., Weldon, W. C., Wei, L., Chen, Q., Shaw, J., Zhao, K., Jorba, J. C., Kew, O. M., Pallansch, M. A., Burns, C. C., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.02.035 · Cited by 14
Weil, M., Shulman, L. M., Heiman, S., Stauber, T., Alfandari, J., Weiss, L., Silberstein, I., Indenbaum, V., Mendelson, E., & Sofer, D. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.47.30408 · Cited by 12
Shaghaghi, M., Irannejad, M., Abolhassani, H., Shahmahmoodi, S., Hamidieh, A. A., Soleymanjahi, S., Yazdani, R., Azizi, G., & Aghamohammadi, A. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0521-z · Cited by 12
Yan, D., Wang, D., Zhang, Y., Li, X., Tang, H., Guan, J. Z., Song, Y., Zhu, S., & Xu, W. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa386 · Cited by 12
The Long and Winding Road to Eradicate Vaccine-Related Polioviruses
Cochi, S. L., & Pallansch, M. A. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa393 · Cited by 9
Makoni, M. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30152-x · Cited by 9
Weil, M., Rahav, G., Somech, R., Stauber, T., Alfandari, J., Weiss, L., Silberstein, I., Indenbaum, V., Or, I. B., Mendelson, E., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.03.037 · Cited by 8
Meyer, E., Sikka, N., Durry, E., & Datta, D. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6934a6 · Cited by 3
Cited by
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
“Less than 1% of polio cases result in temporary or permanent acute flaccid paralysis (AFP) [22].”
BackgroundInfluentialMohanty, A., Rohilla, R., Zaman, K., Hada, V., Dhakal, S., Shah, A., Padhi, B. K., Al‐qaim, Z. H., Altawfiq, K. J. A., Tirupathi, R., et al. (2023) · Infezioni in Medicina · doi:10.53854/liim-3102-5 · Cited by 27
Virus Evolution in Prolonged Infections of Immunocompromised Individuals
Raglow, Z., & Lauring, A. S. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae150 · Cited by 13
Kipterer, J. K., Touray, K., Akpan, G. U., Cisse, A., Babona, N., Ngobe, B., Derrick, C. Y. D., Henry, G. H., Ndoutabé, M., Seaman, V., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307001 · Cited by 9
KITAMURA, K., & Shimizu, H. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2022.312 · Cited by 7
Self-citation
Metadata
- Authors
- Kitamura, K., & Shimizu, H.
- Affiliations
- National Institute of Infectious Diseases (JP)
- Corresponding author
- Shimizu, Hiroyuki
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2021-07-20
- Volume
- 13
- Issue
- 7
- Pages
- 1407
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC8310373
- OpenAlex
- W3184160639
- Cited by
- 14
- References
- 70
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 4
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Agency for Medical Research and Development (JP21fk0108084)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Keywords
- primary immunodeficiency, oral polio vaccine, molecular evolution, polio eradication
- MeSH terms
- Primary Immunodeficiency Diseases, Disease Outbreaks, Humans, Poliovirus Vaccine, Oral, Vaccination, Global Health, Immunocompromised Host, Poliovirus, Evolution, Molecular, Disease Eradication
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.